Previous studies reported that CLL individuals develop T-cell immunity vaccination, despite anti-B-cell treatment that is mainly associated with elevated CD8+ levels, which have been related to improved COVID-19 outcomes (29–31). This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.